Anti-TNFRSF21/DR6/CD358 Antibody is a humanized monoclonal antibody targeting death receptor 6 (DR6, also known as TNFRSF21). It can be used to study DR6-mediated apoptotic signaling pathways, the mechanisms underlying neurodegenerative diseases, and the regulation of the tumor immune microenvironment.
Target:
TNF
T9901A-1403
* VAT and and shipping costs not included. Errors and price changes excepted
